Cardiac Stress Test: the nurse's role, start to finish

What the procedure achieves

A cardiac stress test evaluates how the heart responds to increased workload, either through treadmill exercise or pharmacologic agents like dobutamine or adenosine for patients who cannot exercise adequately. It reveals ischemia that a resting ECG misses, because coronary lesions that are silent at rest can restrict flow under demand.

The test measures heart rate, blood pressure, ECG changes, and symptoms as workload increases in stages, sometimes paired with imaging such as an echocardiogram or nuclear perfusion study to visualise wall motion or perfusion directly. The result guides decisions about further cardiac catheterisation, medication adjustment, or activity clearance.

Pre-procedure nursing responsibilities

Instruct the patient to fast, typically nothing by mouth for three to four hours before the test, since a full stomach increases discomfort during exertion and can affect test accuracy. Instruct the patient to avoid caffeine for at least 24 hours, including decaffeinated coffee which still contains trace amounts, because caffeine can blunt the vasodilator response used in pharmacologic stress testing.

Confirm with the provider whether to hold beta blockers and other rate-controlling medications such as calcium channel blockers. This is not a default hold: beta blockers blunt the heart rate and blood pressure response the test is measuring, so if the goal is to assess maximal cardiac response, the provider will often direct the patient to hold the dose, but this decision belongs to the prescriber, not a standing nursing protocol.

Obtain baseline vital signs, a resting twelve-lead ECG, and verify informed consent is signed. Confirm comfortable footwear and clothing for treadmill testing, and establish IV access if a pharmacologic or imaging agent will be used.

Equipment and positioning

Set up continuous ECG monitoring with properly placed leads before the test begins, along with a blood pressure cuff for manual or automated readings at each exercise stage. Have emergency equipment immediately available, including a crash cart and defibrillator, given the test deliberately provokes cardiac stress in a patient who may have unrecognised disease.

Position the patient upright and mobile for treadmill or bicycle testing, or supine for pharmacologic stress testing with imaging. Ensure the IV line is secured and patent before pharmacologic agents are infused, since agents like adenosine have a very short half-life and any line problem interrupts the test.

Complications and early signs

Watch continuously for chest pain, significant ST-segment changes, dangerous arrhythmias, a drop in blood pressure with increasing workload, or severe dyspnoea, any of which indicate the test should be stopped. A falling systolic blood pressure during exercise is a more urgent warning sign than a rising one, since it suggests the heart cannot meet increasing demand.

With pharmacologic agents, monitor for their specific known effects: adenosine can cause transient flushing, chest tightness, or bronchospasm, and dobutamine can provoke arrhythmia or excessive tachycardia. Report and document any symptom immediately, and be prepared to stop the infusion or the exercise stage on the provider's order or per protocol criteria.

Post-procedure care

Continue ECG and vital sign monitoring during the recovery phase until heart rate and blood pressure return toward baseline, since ischemic changes or arrhythmias can appear during recovery as well as during peak exertion. Keep the patient seated or lying down until they are stable rather than allowing immediate standing or walking away.

Resume held medications per the provider's order once the test is complete and the patient is stable. Document the test tolerance, any symptoms, and the vital sign trend throughout, since this record informs the cardiologist's interpretation alongside the imaging or ECG data.

What to teach before discharge

Tell the patient they may resume their normal diet and any medications held for the test, following the specific instructions given by the provider. Explain that mild fatigue is expected but chest pain, unusual shortness of breath, or palpitations after leaving should prompt a call to the clinic or emergency care.

Give the patient a realistic timeline for results and clarify who will contact them, since anxiety about an undiagnosed heart condition is common after this test. Confirm the patient has transportation arranged if any sedating or vasoactive agent was used, and reinforce that resuming caffeine and normal activity is fine unless told otherwise.